PRNAFAlterity Therapeutics Limited
Price Chart
Loading chart...
About Alterity Therapeutics Limited (PRNAF)
Alterity Therapeutics Limited (PRNAF) is a Biotechnology company headquartered in Melbourne, Australia whose shares trade over-the-counter on the Pink tier.
Alterity Therapeutics Limited creates an alternate, healthier life for people living with neurodegenerative diseases.
PRNAF key facts
- Ticker symbol
- PRNAF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Melbourne, Australia
- Country of incorporation
- AU
- Estimated market cap
- $3.97M (as of May 13, 2025)
- Shares outstanding
- 285,396,900
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 6/30
Alterity Therapeutics Limited leadership
- Geoffrey A. Kempler — CEO
- Richard Revelins — CFO, Secretary
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with P
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Alterity Therapeutics Limited (PRNAF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...